| Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma TH Mouhieddine, O Van Oekelen, DT Melnekoff, J Li, Y Ghodke-Puranik, ... Blood advances 7 (6), 1056-1064, 2023 | 29 | 2023 |
| Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia RJ Daley, S Rajeeve, CC Kabel, JJ Pappacena, SE Stump, JA Lavery, ... Leukemia & Lymphoma 62 (1), 176-184, 2021 | 9 | 2021 |
| Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia ZD Epstein-Peterson, A Derkach, S Geyer, K Mrózek, J Kohlschmidt, ... Blood advances 6 (11), 3433-3439, 2022 | 8 | 2022 |
| Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue E Joffe, Y Leyfman, E Drill, S Rajeeve, AD Zelenetz, ML Palomba, ... Blood advances 5 (2), 345-351, 2021 | 8 | 2021 |
| Hepatic transaminases as predictors of liver injury in abdominal trauma SK Zachariah, V Paul, KS Mathews, J Gopinath, TM Celine, S Rajeeve International Surgery Journal 5 (1), 181-186, 2018 | 7 | 2018 |
| Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world … CB Wagner, K Boucher, A Nedved, IN Micallef, S Desai, H Hatic, G Goyal, ... Haematologica 108 (11), 3025, 2023 | 4 | 2023 |
| How old is too old for CAR-T cell therapies in multiple myeloma? S Rajeeve, SZ Usmani Transplantation and Cellular Therapy, Official Publication of the American …, 2023 | 4 | 2023 |
| Real World Outcomes of Brentuximab Vedotin Maintenance after Autologous Stem Cell Transplant in Relapsed/Refractory Classical Hodgkin Lymphoma: An Time-Variable Analysis of the … CB Wagner, DA Ermann, K Boucher, AN Nedved, IN Micallef, SH Desai, ... Blood 140 (Supplement 1), 9390-9392, 2022 | 4 | 2022 |
| Etiologies and predictors of 30-day readmission in patients undergoing induction chemotherapy for acute myeloid leukemia S Handa, K Gupta, JS Sidhu, G Petrone, S Rajeeve, K Jatwani Blood 134, 4759, 2019 | 3 | 2019 |
| Expectant management of extranodal marginal zone lymphoma of bronchial-associated lymphoid tissue (BALT) Y Leyfman, E Joffe, E Drill, S Rajeeve, AD Zelenetz, MLL Palomba, ... Blood 134, 2826, 2019 | 3 | 2019 |
| Pegaspargase can safely be administered in adults age 40 and older with acute lymphoblastic leukemia RJ Daley, S Rajeeve, CC Kabel, JJ Pappacena, SE Stump, JA Lavery, ... Blood 134, 3816, 2019 | 3 | 2019 |
| Managing Inpatient Constipation: A Docusate Initiative: 1108 E Verheyen, S Rajeeve, S Alipourfetrati, J Sethunarayanan, A Kaplan, ... Official journal of the American College of Gastroenterology| ACG 113, S639, 2018 | 3 | 2018 |
| Multimodal Single-Cell Transcriptomic and Proteomic Correlatives of Patients Outcomes Following Anti-BCMA Cellular Therapy with Ciltacabtagene Autoleucel (Cilta-cel) in … JV dos Santos, D Melnekoff, A Aleman, S Bhalla, TH Mouhieddine, ... Blood 142, 93, 2023 | 2 | 2023 |
| Myelodysplastic Syndromes: Trends in Mortality, Costs of Hospitalizations, Length of Stay and Rate of Complications S Handa, G Petrone, K Gupta, A Khan, JS Sidhu, S Rajeeve Blood 134, 1725, 2019 | 2 | 2019 |
| Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy IS Hamadeh, T Shekarkhand, C Rueda, RS Firestone, AX Wang, N Korde, ... Blood Advances, 2024 | 1 | 2024 |
| Early and Consistent CRS Detection Using Wearable Device for Remote Patient Monitoring Following CAR-T Therapy in Relapsed/Refractory Multiple Myeloma (RRMM): Early Results of … S Rajeeve, N Zahradka, M Wilkes, D Pan, NJ Calafat, K Serebryakova, ... Blood 142, 1007, 2023 | 1 | 2023 |
| Early detection of CRS after CAR-T therapy using wearable monitoring devices: Preliminary results in relapsed/refractory multiple myeloma (RRMM). S Rajeeve, M Wilkes, N Zahradka, K Serebyrakova, K Kappes, H Jackson, ... Journal of Clinical Oncology 41 (16_suppl), e13626-e13626, 2023 | 1 | 2023 |
| P1079: comparison of novel salvage regimens and traditional salvage chemotherapy in relapsed and refractory classic hodgkin lymphoma D Ermann, V Vardell, E Zacholski, A Fegley, D Modi, K Fedak, ... Hemasphere 6, 969-970, 2022 | 1 | 2022 |
| A real-world experience of combined treatment with romidepsin and azacitidine in patients with peripheral T-cell lymphoma. M Kalac, CSL Tam, M Goldfinger, Z Xiao, S Rajeeve, F Montanari, ... Journal of Clinical Oncology 40 (16_suppl), e19550-e19550, 2022 | 1 | 2022 |
| Chimeric Antigen Receptor T-Cell Therapeutics for Multiple Myeloma: Moving Into the Spotlight B Wang, S Rajeeve, D Madduri The Cancer Journal 27 (3), 205-212, 2021 | 1 | 2021 |
